TD Asset Management Inc Makes New $2.22 Million Investment in Astera Labs, Inc. $ALAB

TD Asset Management Inc purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 11,316 shares of the company’s stock, valued at approximately $2,216,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Royal Bank of Canada grew its holdings in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC raised its stake in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC lifted its holdings in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after acquiring an additional 4,183 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in Astera Labs by 3.4% in the second quarter. Envestnet Asset Management Inc. now owns 88,193 shares of the company’s stock valued at $7,974,000 after acquiring an additional 2,903 shares during the period. Finally, Atria Investments Inc acquired a new stake in shares of Astera Labs during the second quarter worth about $226,000. Institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at $179,863,615.59. The trade was a 6.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the sale, the general counsel owned 128,084 shares in the company, valued at $15,046,027.48. The trade was a 7.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 216,792 shares of company stock worth $26,777,569. Insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 3.6%

Shares of NASDAQ ALAB opened at $113.77 on Thursday. The company has a market capitalization of $19.37 billion, a P/E ratio of 93.25, a P/E/G ratio of 2.16 and a beta of 1.74. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a 50 day moving average of $154.84 and a 200-day moving average of $170.88.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on ALAB shares. Citigroup cut their price target on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Morgan Stanley restated an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. Northland Securities raised their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $195.89.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.